Study ID: Abbott 10-392 Absorb III
Title:

A Clinical Evaluation of Absorb¿ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.

Location:
Sioux Falls Region
Principal Investigator:
Tomasz Stys MD
Disease:
Heart
Stage:
N/A

Status:

Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.

Back to Clinical Trials list